111
Views
9
CrossRef citations to date
0
Altmetric
Technology Evaluation

The MediChew® technology platform

, , , &
Pages 927-933 | Published online: 16 Sep 2005

Bibliography

  • FERTIN PHARMA A/S: Internal report. (2002).
  • RASSING MR: Specialised oral mucosal drug delivery dystems: chewing gum. In: Oral Mucosa] Drug Delivery MJ Rathbone (Ed.), Marcel Dekker, Inc., NY, USA (1996) 331.
  • ••Excellent review that covers the literatureon medical chewing gum at the time of publication.
  • KATSURAGI Y, KURIHARA K: Specific inhibitor for bitter taste. In: Modifying Bitterness. G Roy (Ed.), Technonomic Publishing company, Inc., Lancaster, PA, USA (1997) 255–281.
  • Dissolution test for medicated chewing gums. In: European Pharmacopeia. 5(2.9.25).
  • PERM) OVE: A substitute for tobacco smoking. Psychopharmacologica (1973) 31:201–204.
  • RASSING MR: Chewing gum as a drug delivery system. Adv. Drug Delivery Rev. (1994) 13:89–121.
  • ••Excellent review summarising the progressIn the literature on medical chewing gum up to the date of publication.
  • CHRISTRUP LL, DAVIS SS, FRIER M et al.: Deposition of a model substance, ggmTcE-HIDA, in the oral cavity after administration of lozenges, chewing gum and sublingual tablets. Int. J. Pharmaceutics (1990) 66:169–174.
  • BENOWITZ NL, JACOB P 3 SAVANAPRIDI C: Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin. Pharmacol Ther. (1987) 41:467–473.
  • SILAGY C, LANCASTER T, STEAD L, MANT D, FOWLER G: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2002) (4) :CD000146.
  • BOUSQUET E, TIRENDI S, BONINA FP, MONTENEGRO L, BIANCHI A, CIAMPINI N: Bioavailability of two formulations of acetylsalicylic acid gums. Pharmazie (1992) 47(H.8):607–609.
  • WOODFORD DW, LESKO LJ: Relative bioavailability of aspirin gum. J. Pharm. Sciences (1981) 70(12):1341–1343.
  • SKOFITSCH G, LEMBECK F: Serum levels of dimenhydrinate. Determination by HPLC with UV detection after intake of dimenhydrinate in a coated chewing gum dragee. Arzneimittelforschung (1983) 33(12):1674–1676.
  • KAMIMORI GH, KARYEKAR CS, OTTERSTETTER R et al: The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int. .1. Pharmaceutics (2002) 234:159–167.
  • •An interesting comparison between chewing gum and capsules as delivery systems for caffeine.
  • JESSEN AB, TOUBRO S, ASTRUP A: Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men. Am. Clin. Num. (2003) 77:1442–1447.
  • •A review discussing how the combination of nicotine and caffeine in chewing gum may constitute an alternative smoking cessation aid that reduces weight gain after discontinued smoking.
  • ANKERSEN L, JESSEN A. TOUBRO S, ASTRUP A: The effect of a nicotine and caffeine chewing gum on appetite in lean non smoking males. Int. J. Obesity (2002) 26:158.
  • CHRISTRUP LL, BONDE J, RASMUSSEN SN, RASSING MR: Relative bioavailability of (±)-verapamil hydrochloride administered in tablets and chewing gum. Acta Pharm. Nord. (1990) 2(6):371–376.
  • CHRISTRUP LL, ANGELO HR, BONDE J, KRISTENSEN F, RASMUSSEN SN: Relative bioavailability of methadone hydrochloride administered in chewing gum and tablets. Acta Pharm. Nord (1990) 2(2):83–88.
  • PEDERSEN M, RASSING MR: Miconazole chewing gum as a drug delivery system. Test of release promoting additives. Drug Dev. Industrial Pharmacy (1991) 17(3):411–420.
  • RINDUM JL, HOLMSTRUP P, PEDERSEN M, RASSING MR, STOLTZE K: Miconazole chewing gum for treatment of chronic oral candidosis. Land. J. Dent. Res. (1993) 101:386–390.
  • BASTIAN HL, RINDUM J, LINDEBERG H: A double-dummy, double-blind, placebo-controlled Phase III study comparing the efficacy and efficiency of miconazole chewing gum with a known drug (Brentan® gel) and a placebo in patients with oral candidosis. Oral Surg. Oral Med. Oral Pathol. Oral Radio]. Endod. (2004) 98(4):423–428.
  • •A review discussing how patients found miconazole chewing gum more convenient than the gel. The same effect was obtained with 10-fold the dose in chewing gum compared with gel.
  • SJOGREN K, BIRKHED D, PERSSON LG, NOREN JG: Salivary fluoride clearance after a single intake of fluoride tablets and chewing gums in children, adults, and dry mouth patients. Land. J. Dent. Res. (1993) 101:274–278.
  • SJOGREN K, LINGSTROM P, LUNDBERG A- BIRKHED D: Salivary fluoride concentration and plaque pH after using a fluoride-containing chewing gum. Caries Res. (1997) 31:366–372.
  • SJOGREN K, RUBEN J, BIRKHED D: Fluoride chewing gum in an intraoral caries model. J. Dent. Res. (1999) 78:202.
  • LAMB WJ, CORPRON RE, MORE FG, BELTRAN ED, STRACHAN DS, KOWALSKI CJ: In situ remineralization of subsurface enamel lesion after the use of a fluoride chewing gum. Caries Res. (1993) 27:111–116.
  • AINAMO J, NIEMINEN A, WESTERLUND U: Optimal dosage of chlorhexidine acetate in chewing gum. Periodontol. (1990) 17:729–733.
  • SMITH AJ, MORAN J, DANGLER LV, LEIGHT RS, ADDY M: The efficacy of an anti-gingivitis chewing gum. Periodontol. (1996) 23:19–23.
  • SIMONS D, KIDD EAM, BEIGHTON D, JONES B: The effect of chlorhexidine/xylitol chewing-gum on cariogenic salivary microflora: a clinical trial in elderly patients. Caries Res. (1997) 31:91–96.
  • SIMONS D, BEIGHTON D, KIDD EAM, COLLIER Fl: The effect of xylitol and chlorhexidine acetate/xylitol chewing gums on plaque accumulation and gingival inflammation. J. Clin. Periodontol. (1999) 26:388–391.
  • SIMONS D, BAKER P, KNOTT D, RUSH S, BRIGGS T, KIDD EA, BEIGHTON D: Attitudes of carers and the elderly occupants of residential homes to antimicrobial chewing gum as an aid to oral health. BE Dent. J. (1999) 187(10:612–615.
  • SIMONS D, BRAILSFORD S, KIDD EA, BEIGHTON D: The effect of chlorhexidine acetate/xylitol chewing gum on the plaque and gingival indices of elderly occupants in residential homes. J. Clin. Peridontol. (2001) 28:1010–1015.
  • SIMONS D, BRAILSFORD SR, KIDD EA, BEIGHTON D: The effect ofmedicated chewing gums on oral health in frail older people: a 1-year clinical trial. J. Am. Ceriatr. Soc. (2002) 50:1348–1353.
  • SCHONFELD JV, HECTOR M, EVANS DF, WINGATE DL: Oesophageal acid and salivary secretion: is chewing gum a treatment option for gastro-oesophageal reflux? Digestion (1997) 58:111–114.
  • AVIDAN B, SONNENBERG A, SCHNELL TG, SONTAG SJ: Walking and chewing reduce postprandial acid reflux. Ailment. Pharmacol. Ther. (2001) 15:151–155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.